{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jankowitz BT"],"funding":["Stryker Neurovascular"],"pagination":["143-148"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8785011"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(2)"],"pubmed_abstract":["<h4>Background</h4>Stent-assisted coiling of wide-necked intracranial aneurysms (IAs) using the Neuroform Atlas Stent System (Atlas) has shown promising results.<h4>Objective</h4>To present the primary efficacy and safety results of the ATLAS Investigational Device Exemption (IDE) trial in a cohort of patients with posterior circulation IAs.<h4>Methods</h4>The ATLAS trial is a prospective, multicenter, single-arm, open-label study of unruptured, wide-necked, IAs treated with the Atlas stent and adjunctive coiling. This study reports the results of patients with posterior circulation IAs. The primary efficacy endpoint was complete aneurysm occlusion (Raymond-Roy (RR) class I) on 12-month angiography, in the absence of re-treatment or parent artery stenosis >50%. The primary safety endpoint "],"journal":["Journal of neurointerventional surgery"],"pubmed_title":["Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes."],"pmcid":["PMC8785011"],"funding_grant_id":["Industry funded with no grant."],"pubmed_authors":["Hallam DK","Jankowitz BT","Thomas A","Fraser JF","Zaidat OO","Siddiqui AH","Crowley RW","Reavey-Cantwell J","Turk AS","Klucznik R","Caplan JM","Colby GP","Alhajeri AA","Frei D","Spiotta AM","Toth G","Bellon R","Lopes DK","Froehler MT","Aghaebrahim A","Puri AS","Arthur AS","Kan P","Satti SR","Khaldi A","Malek AM","Callison RC","Sauvageau E","Jadhav AP","Gross B","Hanel RA","Lin E","Kung D","Loy D","Alexander MJ","Jovin TG","Hetts SW"],"additional_accession":[]},"is_claimable":false,"name":"Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes.","description":"<h4>Background</h4>Stent-assisted coiling of wide-necked intracranial aneurysms (IAs) using the Neuroform Atlas Stent System (Atlas) has shown promising results.<h4>Objective</h4>To present the primary efficacy and safety results of the ATLAS Investigational Device Exemption (IDE) trial in a cohort of patients with posterior circulation IAs.<h4>Methods</h4>The ATLAS trial is a prospective, multicenter, single-arm, open-label study of unruptured, wide-necked, IAs treated with the Atlas stent and adjunctive coiling. This study reports the results of patients with posterior circulation IAs. The primary efficacy endpoint was complete aneurysm occlusion (Raymond-Roy (RR) class I) on 12-month angiography, in the absence of re-treatment or parent artery stenosis >50%. The primary safety endpoint ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2026-06-07T07:30:17.233Z","creation":"2025-04-04T07:52:10.917Z"},"accession":"S-EPMC8785011","cross_references":{"pubmed":["33722961"],"doi":["10.1136/neurintsurg-2020-017115"]}}